Jackson Grant Investment Advisers’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
Jackson Grant Investment Advisers's EXAS Position: Q4 2021 in Review
Jackson Grant Investment Advisers sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 212 shares — an estimated $20K sold.
Jackson Grant Investment Advisers first reported a position in EXAS in Q4 2020 and held it in 4 quarters. The position peaked at $53K in Q1 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.
- Jackson Grant Investment Advisers reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
- Jackson Grant Investment Advisers sold 212 Exact Sciences shares in Q4 2021, an estimated $20K.
- Jackson Grant Investment Advisers first reported a position in Exact Sciences in Q4 2020 and held it in 4 quarters.
- Jackson Grant Investment Advisers's Exact Sciences position peaked at $53K in Q1 2021.
- 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.
Based on Jackson Grant Investment Advisers's 13F filing for Q4 2021, filed 24 Jan 2022.